Rezolute Eulerpool Nyheder

Rezolute Aktie Nyheder

Rezolute bliver overvåget af mange journalister og investorer over hele verden. De seneste Rezolute nyheder samler vi her.

• 9. juli ·

  Yahoo
  Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)
• 2. juni ·

  Yahoo
  Rezolute, Inc. (NASDAQ:RZLT) is a favorite amongst institutional investors who own 77%
• 25. april ·

  Yahoo
  Rezolute, Inc. Announces Closing of Underwritten Offering
• 18. februar ·

  SeekingAlpha
  Rezolute: Late-Stage Study Targeting Hyperinsulinism
• 7. januar ·

  Yahoo
  Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
• 5. december ·

  Yahoo
  Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
• 3. december ·

  Yahoo
  FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
• 13. november ·

  Yahoo
  We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully
• 7. november ·

  Yahoo
  Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
• 5. november ·

  Yahoo
  Rezolute to Participate in Upcoming Investor Conferences